Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SWARMER, INC (SWMR)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Swarmer and Molfar Partner to Integrate Verified Intelligence Data for Autonomous Systems

Market reaction Comment Full text

ASML HOLDING NV (ASML)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

ASML reports transactions under its current share buyback program

Market reaction Comment Full text

SPRUCE BIOSCIENCES, INC. (SPRB)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller

Market reaction Comment Full text

ONESPAN INC. (OSPN)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

The Shift to Digital Credentials Accelerates: OneSpan Launches Early Access at Identiverse

Market reaction Comment Full text

VISTANCE NETWORKS, INC. (VISN)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

RUCKUS Networks Reimagines Hospitality Networks in the AI Era to Improve Operational Efficiency and Protect Revenue

Market reaction Comment Full text

VONTIER CORP (VNT)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Vontier Earns Top Accolade at International Sustainability Awards

Market reaction Comment Full text

SEER, INC. (SEER)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction

Market reaction Comment Full text

IRON HORSE ACQUISITION II CORP. (IRHO)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

ELECTRA AI to Participate in ROTHs 16th Annual London Conference, June 16-18, 2026

Market reaction Comment Full text

NEUMORA THERAPEUTICS, INC. (NMRA)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update

Market reaction Comment Full text

OPKO HEALTH, INC. (OPK)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Preclinical Data for OPKO Biologics OPK8801001 in Acromegaly Presented at ENDO 2026

Market reaction Comment Full text
  • Previous
  • 53
  • 54
  • 55
  • 56
  • 57
  • Next

Search

News categories

  • Technical Exchange News(13172)
  • Event(6229)
  • SEC News(330643)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(184378)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin